Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005930 | axoneme | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HNU2
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 11 |
GO:0003824 | catalytic activity | 1 | 11 |
GO:0003924 | GTPase activity | 7 | 11 |
GO:0005488 | binding | 1 | 11 |
GO:0005525 | GTP binding | 5 | 11 |
GO:0016462 | pyrophosphatase activity | 5 | 11 |
GO:0016787 | hydrolase activity | 2 | 11 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 3 | 11 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 4 | 11 |
GO:0017076 | purine nucleotide binding | 4 | 11 |
GO:0017111 | ribonucleoside triphosphate phosphatase activity | 6 | 11 |
GO:0019001 | guanyl nucleotide binding | 5 | 11 |
GO:0032553 | ribonucleotide binding | 3 | 11 |
GO:0032555 | purine ribonucleotide binding | 4 | 11 |
GO:0032561 | guanyl ribonucleotide binding | 5 | 11 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 11 |
GO:0036094 | small molecule binding | 2 | 11 |
GO:0043167 | ion binding | 2 | 11 |
GO:0043168 | anion binding | 3 | 11 |
GO:0097159 | organic cyclic compound binding | 2 | 11 |
GO:0097367 | carbohydrate derivative binding | 2 | 11 |
GO:1901265 | nucleoside phosphate binding | 3 | 11 |
GO:1901363 | heterocyclic compound binding | 2 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_KEX2_1 | 82 | 84 | PF00082 | 0.419 |
CLV_PCSK_PC1ET2_1 | 82 | 84 | PF00082 | 0.419 |
CLV_PCSK_SKI1_1 | 188 | 192 | PF00082 | 0.305 |
CLV_PCSK_SKI1_1 | 26 | 30 | PF00082 | 0.566 |
CLV_PCSK_SKI1_1 | 40 | 44 | PF00082 | 0.343 |
CLV_PCSK_SKI1_1 | 83 | 87 | PF00082 | 0.311 |
DEG_APCC_DBOX_1 | 39 | 47 | PF00400 | 0.468 |
DOC_CYCLIN_RxL_1 | 23 | 33 | PF00134 | 0.551 |
DOC_CYCLIN_RxL_1 | 37 | 47 | PF00134 | 0.411 |
DOC_MAPK_gen_1 | 111 | 119 | PF00069 | 0.348 |
DOC_MAPK_gen_1 | 186 | 193 | PF00069 | 0.365 |
DOC_MAPK_gen_1 | 80 | 87 | PF00069 | 0.417 |
DOC_MAPK_MEF2A_6 | 111 | 119 | PF00069 | 0.379 |
DOC_MAPK_MEF2A_6 | 186 | 193 | PF00069 | 0.325 |
DOC_USP7_MATH_1 | 261 | 265 | PF00917 | 0.550 |
DOC_WW_Pin1_4 | 111 | 116 | PF00397 | 0.316 |
LIG_14-3-3_CanoR_1 | 168 | 176 | PF00244 | 0.243 |
LIG_14-3-3_CanoR_1 | 83 | 88 | PF00244 | 0.419 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.540 |
LIG_EH_1 | 33 | 37 | PF12763 | 0.481 |
LIG_FHA_1 | 112 | 118 | PF00498 | 0.255 |
LIG_FHA_1 | 227 | 233 | PF00498 | 0.392 |
LIG_FHA_1 | 23 | 29 | PF00498 | 0.495 |
LIG_FHA_1 | 96 | 102 | PF00498 | 0.283 |
LIG_FHA_2 | 235 | 241 | PF00498 | 0.453 |
LIG_GBD_Chelix_1 | 238 | 246 | PF00786 | 0.417 |
LIG_LIR_Gen_1 | 250 | 261 | PF02991 | 0.423 |
LIG_LIR_Gen_1 | 33 | 43 | PF02991 | 0.465 |
LIG_LIR_Nem_3 | 116 | 122 | PF02991 | 0.389 |
LIG_LIR_Nem_3 | 152 | 157 | PF02991 | 0.449 |
LIG_LIR_Nem_3 | 250 | 256 | PF02991 | 0.401 |
LIG_LIR_Nem_3 | 33 | 39 | PF02991 | 0.446 |
LIG_NRBOX | 38 | 44 | PF00104 | 0.545 |
LIG_PCNA_PIPBox_1 | 13 | 22 | PF02747 | 0.374 |
LIG_PCNA_yPIPBox_3 | 12 | 20 | PF02747 | 0.379 |
LIG_Pex14_1 | 146 | 150 | PF04695 | 0.305 |
LIG_Pex14_2 | 142 | 146 | PF04695 | 0.305 |
LIG_SH2_CRK | 154 | 158 | PF00017 | 0.197 |
LIG_SH2_CRK | 224 | 228 | PF00017 | 0.259 |
LIG_SH2_CRK | 253 | 257 | PF00017 | 0.533 |
LIG_SH2_STAP1 | 253 | 257 | PF00017 | 0.500 |
LIG_SH2_STAT3 | 10 | 13 | PF00017 | 0.398 |
LIG_SH2_STAT5 | 113 | 116 | PF00017 | 0.450 |
LIG_SH2_STAT5 | 158 | 161 | PF00017 | 0.339 |
LIG_SH2_STAT5 | 184 | 187 | PF00017 | 0.367 |
LIG_SH2_STAT5 | 38 | 41 | PF00017 | 0.472 |
LIG_SH3_3 | 29 | 35 | PF00018 | 0.496 |
LIG_SH3_5 | 125 | 129 | PF00018 | 0.414 |
LIG_SUMO_SIM_par_1 | 98 | 106 | PF11976 | 0.367 |
LIG_TYR_ITIM | 175 | 180 | PF00017 | 0.197 |
LIG_UBA3_1 | 19 | 26 | PF00899 | 0.509 |
LIG_UBA3_1 | 190 | 197 | PF00899 | 0.348 |
MOD_CK1_1 | 162 | 168 | PF00069 | 0.417 |
MOD_CK2_1 | 234 | 240 | PF00069 | 0.311 |
MOD_CK2_1 | 75 | 81 | PF00069 | 0.439 |
MOD_CK2_1 | 99 | 105 | PF00069 | 0.450 |
MOD_GlcNHglycan | 105 | 108 | PF01048 | 0.320 |
MOD_GlcNHglycan | 161 | 164 | PF01048 | 0.304 |
MOD_GlcNHglycan | 77 | 80 | PF01048 | 0.696 |
MOD_GSK3_1 | 52 | 59 | PF00069 | 0.482 |
MOD_GSK3_1 | 95 | 102 | PF00069 | 0.325 |
MOD_N-GLC_2 | 130 | 132 | PF02516 | 0.417 |
MOD_NEK2_1 | 176 | 181 | PF00069 | 0.394 |
MOD_NEK2_1 | 22 | 27 | PF00069 | 0.468 |
MOD_PIKK_1 | 56 | 62 | PF00454 | 0.669 |
MOD_PIKK_1 | 72 | 78 | PF00454 | 0.667 |
MOD_PKA_2 | 167 | 173 | PF00069 | 0.319 |
MOD_Plk_2-3 | 234 | 240 | PF00069 | 0.353 |
MOD_Plk_4 | 234 | 240 | PF00069 | 0.236 |
MOD_Plk_4 | 99 | 105 | PF00069 | 0.361 |
MOD_ProDKin_1 | 111 | 117 | PF00069 | 0.316 |
MOD_SUMO_for_1 | 267 | 270 | PF00179 | 0.519 |
MOD_SUMO_rev_2 | 105 | 114 | PF00179 | 0.450 |
TRG_DiLeu_BaLyEn_6 | 186 | 191 | PF01217 | 0.348 |
TRG_ENDOCYTIC_2 | 154 | 157 | PF00928 | 0.197 |
TRG_ENDOCYTIC_2 | 177 | 180 | PF00928 | 0.349 |
TRG_ENDOCYTIC_2 | 224 | 227 | PF00928 | 0.234 |
TRG_ENDOCYTIC_2 | 253 | 256 | PF00928 | 0.388 |
TRG_ENDOCYTIC_2 | 38 | 41 | PF00928 | 0.495 |
TRG_Pf-PMV_PEXEL_1 | 174 | 178 | PF00026 | 0.424 |
TRG_Pf-PMV_PEXEL_1 | 197 | 201 | PF00026 | 0.389 |
TRG_Pf-PMV_PEXEL_1 | 40 | 45 | PF00026 | 0.579 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P886 | Leptomonas seymouri | 69% | 94% |
A0A0S4JWF1 | Bodo saltans | 43% | 100% |
A0A1X0P0D4 | Trypanosomatidae | 28% | 100% |
A0A1X0P850 | Trypanosomatidae | 55% | 100% |
A0A221LG87 | Leishmania donovani | 30% | 100% |
A0A3S5H5A9 | Leishmania donovani | 31% | 100% |
A0A3S7XAE0 | Leishmania donovani | 81% | 96% |
A0A422NK26 | Trypanosoma rangeli | 54% | 89% |
A4H3W8 | Leishmania braziliensis | 30% | 100% |
A4HS43 | Leishmania infantum | 31% | 100% |
A4HSC6 | Leishmania infantum | 30% | 100% |
A4ICQ2 | Leishmania infantum | 81% | 95% |
D0A2Q7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 48% | 100% |
E9AKA7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 30% | 100% |
E9ASK2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 80% | 95% |
Q3SXY8 | Homo sapiens | 35% | 67% |
Q4Q1Z4 | Leishmania major | 81% | 100% |
Q4QJK0 | Leishmania major | 30% | 100% |
Q5H913 | Homo sapiens | 30% | 99% |
Q640N2 | Mus musculus | 37% | 67% |
Q6AXT3 | Rattus norvegicus | 31% | 73% |
Q8JHI3 | Danio rerio | 36% | 71% |
Q9D416 | Mus musculus | 30% | 77% |
Q9U0T6 | Leishmania major | 30% | 100% |